ライフサイエンスコーパス: visit

1 t enrolled), to April 21, 2016 (last patient visit).

2 sit) to February 2013 (last participant last visit).

3 tive control participants contributed 27 409 visits).

4 -0.80 for one visit; 0.51, 0.31-0.84 for two visits).

5 ively, but only 65% received IPV at the same visit.

6 ues to address during an upcoming oncologist visit.

7 color photographs were acquired on the same visit.

8 umption of an LCS-containing food before her visit.

9 c evaluation was performed at each follow-up visit.

10 was assessed by ultrasound at each research visit.

11 d in the cohort, and 11,193 completed a home visit.

12 were compared at baseline and last follow-up visit.

13 linical examination and keratometry at every visit.

14 f women knew their HIV status after the CHiP visit.

15 BCVA at each visit.

16 to 1.76]) after adjustment for reason for ED visit.

17 nd degree of exudation were recorded at each visit.

18 with 1 or 2 injectable vaccines in a single visit.

19 ntibody (GADA, IAA, or IA-2A) on two or more visits.

20 Prevalence was defined as >/=2 IBD-related visits.

21 atings completed every 2 weeks during clinic visits.

22 tinued to experiment with the order of later visits.

23 xaminations during recruitment and follow-up visits.

24 le of length for age at more than half their visits.

25 y and endoscopy was masked to allocation and visits.

26 via tablet computers at 5 successive clinic visits.

27 ozone effects on asthma emergency department visits.

28 ad greater than 5 dB MD variation in between visits.

29 correlated with VA at baseline and follow-up visits.

30 of birth, and number of previous healthcare visits.

31 6925 (58%) attended one or more surveillance visits.

32 specific concordance were assessed at annual visits.

33 care and inappropriate emergency department visits.

34 artery disease (CAD) was present in 24.3% of visits.

35 ipants who were unable to complete all study visits.

36 culated using data from six monthly clinical visits.

37 ts, or at 1 visit with >/=1 criteria at >/=2 visits.

38 03,257,516 annual adult emergency department visits.

39 fe threatening in 16% of diplopia-related ED visits.

40 ints during the first and the last follow-up visits.

41 ters were assessed at baseline and at yearly visits.

42 hildren received during their 2- and 4-month visits.

43 3.0 days compared with in-person dermatology visits.

44 an IOH in an eye on at least 1 of the e-ROP visits.

45 vs 48.1 (22.3) years for diplopia-related ED visits.

46 elf-reported dietary intakes at each monthly visit (0.5-4.5 mo).

47 he antibiotic prescription rate per 1000 PED visits (-0.4% per 15-day period, P = .04), and the cumul

48 hazard ratio 0.57, 95% CI 0.40-0.80 for one visit; 0.51, 0.31-0.84 for two visits).

49 e cycle ergometry was performed at baseline (visit 1) and after each week (visits 2 and 3).

50 During Visit 1, 356 (39.3%) participants were graded with a nor

51 95% CI 377.8-565.8 mumol/L) versus baseline (visit 1: 38.0, 95% CI 0.00-132.0 mumol/L; P<0.001).

52 study of all patients >/=10 years of age who visited 1 of the 13 Khayelitsha ART clinics from 2013-20

53 ility of remaining in the same class between visits 1 and 2 and between visits 2 and 3.

54 ing in the monogamous class was 0.51 between visits 1 and 2.

55 lth resources (odds ratio>/=2 emergency room visit, 1.41 [95% confidence interval, 1.09-1.81]; odds r

56 During the follow-up visit, 11054 (2.6%) cases were found to have psoriasis.

57 Among 2520 registry visits, 1221 were excluded for transfer from another med

58 t rates of postdischarge readmissions and ED visits (14.4% and 16.3%, respectively, P < 0.001).

59 e frequently (59.7%) than non-cancer-related visits (16.3%) (P < .001).

60 nitric oxide metabolites occurred with KNO3 (visit 2: 199.5, 95% CI 98.7-300.2 mumol/L; visit 3: 471.

61 d at baseline (visit 1) and after each week (visits 2 and 3).

62 ame class between visits 1 and 2 and between visits 2 and 3.

63 ad undetectable drug concentrations at every visit, 2 had low concentrations at the seroconversion vi

64 73 m(2) and >/=30% eGFR decline at the third visit (2009-2013) relative to baseline among those parti

65 from the primary diagnosis for 13832 office visits (2010-2013 National Ambulatory Medical Care Surve

66 dpoint was clinical cure at the test-of-cure visit (21-25 days after randomisation).

67 (mMIDI; primary analysis) was stable across visits: 28.6% (306/1069) at baseline, 29.3% (292/995) at

68 (visit 2: 199.5, 95% CI 98.7-300.2 mumol/L; visit 3: 471.8, 95% CI 377.8-565.8 mumol/L) versus basel

69 265 adult patients with advanced cancer who visited 38 oncologists within community- and hospital-ba

70 howed a significant reduction in CSF SOD1 at visit 6 (p < 0.001) with a mean reduction of 13.5% (95%

71 ingle-Item Scale were measured at screening, visit 6, and visit 9.

72 At last visit, 6 of 27 (22%) patients had nystagmus and 12 of 20

73 ese participants contributed a total of 1058 visits, 67 (6.3%) of which preceded new-onset BPSD withi

74 ht up QPL-related topics during their office visits (70.2% v 32.6%; P < .001).

75 confidence interval [CI] = 8.4-18.5) and at visit 9 (p < 0.001) with a mean reduction of 10.5% (95%

76 ale were measured at screening, visit 6, and visit 9.

77 Self-reports were completed at 1202 visits (93.9% overall adherence).

78 nd a 1.6% increase in GP-referred specialist visits (95% CI 1.2%-2.0%; p < 0.001) per quarter, equiva

79 his cohort study included adult patients who visited a tertiary Lyme center between January 2008 and

80 participants in the Dallas Heart Study at 2 visits a mean of 8 years apart.

81 after each interruption for meals or toilet visits, a 37 degrees x45 degrees OCT volume scan was per

82 e summarized from coaching notes; one office visit after the coaching session was audio recorded, tra

83 care/Medicaid coverage and more cardiologist visits after discharge and who participated in cardiac r

84 in each of the 155 countries and territories visit all vaccine stores as well as a 10% sample of high

85 There were 1.06 million ED visits among patients from 17 Medicaid expansion states,

86 dicaid expansion states, and 7.87 million ED visits among patients from 19 nonexpansion states.

87 We identified all enrollees visiting an ED for ocular conditions identified by Inter

88 ations between whether a respondent reported visiting an HCP about CeD in the last five years and the

89 The most frequent reason for not visiting an HCP was "doing fine on my own" (47.6%).

90 defined as >/=2 IBD-related visits with one visit and >/=1 dispensed IBD-related drug prescription i

91 m questionnaires administered at the initial visit and 1 year later, as well as baseline risk factor

92 ll, 36% of participants reported an eye care visit and 21% reported a dilated examination in the past

93 current weight was measured at each research visit and abstracted from prenatal records.

94 easured weight at the first antenatal clinic visit and at 18 mo postpartum.The median retained weight

95 Patients underwent evaluation at the initial visit and follow-up at 2 weeks and 3, 6, 9, and 12 month

96 Adverse event data were collected at each visit and included an assessment of the corticosteroid r

97 Per-visit and total costs increased across all age groups.

98 loss from the best previous measurement at 1 visit and vision not better than at baseline.

99 (with a mean of 26.8 million new outpatient visits and 14.9 million inpatient admissions per year).

100 seropositive participants contributed 20 477 visits and 2808 HIV-seronegative control participants co

101 nosis obtained from inpatient and outpatient visits and defined using International Classification of

102 espiratory disease emergency department (ED) visits and examined between-city heterogeneity in estima

103 ted with increased risk of asthma-related ED visits and hospitalizations.

104 uctions in anxiety and unscheduled physician visits and increases in self-efficacy, but definitive co

105 Statistics) on all NHS outpatient specialist visits and inpatient hospital admissions in England betw

106 dose-dependent increase in postdischarge ED visits and readmission for pain-related diagnoses, but n

107 ort their own symptomatic AEs at most clinic visits and report more AEs than investigators.

108 The number of ED visits and total cost associated with HZ increased betwe

109 s of diarrhea were documented through clinic visits and twice-weekly house visits through 52 weeks.

110 d motor function tests during routine clinic visits and with serial functional brain imaging studies,

111 had low concentrations at the seroconversion visit, and 1 had variable concentrations.

112 on to return for at least one PrEP follow-up visit, and greater than 90% adherence to PrEP.

113 ere performed at baseline and each follow-up visit, and LMX1A-rs4657412 was genotyped in all particip

114 y (<90 vs >/=90) determined at the screening visit, and randomly assigned 1:1 to treatment using an i

115 United States annually; 95% were outpatient visits, and diagnoses were rarely serious in the ambulat

116 tions at risk for 30-day readmissions and ED visits, and do not seem to be mediated by postdischarge

117 erences, in-person meetings, site monitoring visits, and internal and external quality assurance test

118 ng up to nearly 850,000 emergency department visits annually.

119 spital readmissions and emergency department visits as separate event types is proposed.

120 ge z score from baseline to the end-of-study visit at 24 months.

121 luded 3-day Holter ECG recordings and office visits at 3, 6, and 12 months.

122 with an increased risk of emergency hospital visits at lag 0-2 days (cumulative relative risk [RRs] 1

123 ccess criterion was not met at 2 consecutive visits at least 3 months after the surgery.

124 inase autoantibodies at 2 consecutive clinic visits at least 3 months apart.

125 Return visits at which the patient reported blurry vision on th

126 n 61 days or 18 years or older, leaving 1299 visits available for analysis.

127 randomization visit to the 6-month follow-up visit, based on the best-corrected electronic Early Trea

128 declined screening; n = 600), or usual care (visit-based screening; n = 600).

129 similar rates, whereas the first few feeder visits became fixed early while bees continued to experi

130 mained unchanged when compared with the last visit before rejection (BSCVA, 0.15+/-0.11 logMAR; CCT,

131 SD) age of study participants at their first visit between 1963 and 1974 was 42.94 (1.73) years and m

132 re longitudinally assessed with 27 022 study visits between 1986 and 2016 in nine cohorts from North

133 completed >/=1 of 5 consecutive quinquennial visits between 1987 and 2010, resulting in a total follo

134 were extracted at the initial and follow-up visits between 2007 and 2014.

135 Center, UPMC) among adults seen in an office visit by a UPMC-employed primary care physician (PCP) in

136 measured at baseline and at every restaging visit by using the MD Anderson Symptoms Inventory.

137 Households of index patients were visited by fieldworkers within 2 weeks of diagnosis.

138 ated multimodal cues from individual flowers visited by hoverflies in three different environments (h

139 c data were collected at baseline and yearly visits by means of a standardized collection form.

140 r decentralised care plus structured support visits by trained community health workers (intervention

141 0.012; p=0.545), but there was a significant visit-by-treatment interaction (p=0.0018).

142 even though the number of scavenger species visiting carcasses and the time needed by scavengers to

143 At each visit, clinical and laboratory (including HIV) assessmen

144 derestimations by all models except JeDi and VISIT compared to observation-based average k), likely c

145 ortation, home appointment) and reminder for visit compared with low-ranking interventions related to

146 or children who were overweight/obese at all visits compared with normal weight children]) analyses.

147 uiring hospitalization and/or emergency room visits compared with placebo in patients with severe eos

148 e treatment completion and monthly follow-up visit compliance rates were higher in the 12-week RPT/IN

149 tion questions and the percentages of office visit conditions or hospital stay conditions seen were l

150 ata after outpatient mental health specialty visits could be developed to predict suicides among outp

151 , and >4.00 IU/mL) at the intermediate study visit (day 336) and determined risk of progression to ac

152 of ED visits]) while the proportion of ED HZ visits decreased for patients aged less than 20 years an

153 irst birth, they seek care later, make fewer visits during pregnancy, and receive fewer components of

154 ia a mobile app to avert in-person follow-up visits during the first 30 days after the operation.

155 At quarterly maintenance or prophylaxis visits during the subsequent year, therapeutic response

156 Data collectors visited each woman in pregnancy, within 72 h of her baby

157 nce ages suggest that Neandertals repeatedly visited 'Ein Qashish between 70 and 60 ka.

158 repeated rapid HIV testing during home-based visits every 6 months for about 4 years in four clusters

159 Staff masked to allocation made home visits every week from enrolment to 6 months after deliv

160 jects with more than 4 semi-annual follow-up visits (every 6 months) in the multicenter Advanced Imag

161 these clinical failure criteria at follow-up visits: fever; increase in erythema (>25%), swelling, or

162 Each patient then had every visit for 2 years reviewed twice, once for billing data

163 s who were rehospitalized or had a return ED visit for asthma within 30 days of an index hospitalizat

164 derwent surgery 1 month after their baseline visit for implantation of the dual lead DBS system.

165 ED visits for all internal causes were associated with heat

166 Same-day OP(DTT) was not associated with ED visits for any outcome.

167 The overall odds ratio (OR) for ER visits for GI illness was 1.09 [95% confidence interval

168 Emergency department visits for MVCs.

169 e the frequency of emergency department (ED) visits for nonurgent and urgent ocular conditions and ri

170 he epidemiology of U.S. emergency department visits for sepsis.

171 We assessed the frequency of ED visits for urgent and nonurgent ocular conditions and ho

172 sit, participants had 4 additional in-person visits, for a total of 5 in-person visits, hospitalizati

173 and clinical parameters throughout all study visits found inflammation around teeth and implants posi

174 g an estimated 696 million weighted adult ED visits from January 2006 to December 2012, 29.5 million

175 collected daily counts of emergency hospital visits from the 28 largest hospitals in 26 Chinese citie

176 sured after doses 1 and 8, then 1 (follow-up visit [FUV] 1) and 3 (FUV2) weeks after final dose.

177 ctiveness of offering vaccination to MSM who visit genitourinary medicine (GUM) clinics.

178 Among couples with HPV results at all visits, >/=1 of the same genotypes were detected in both

179 long setae, suggesting its possible habit of visiting gymnosperm reproductive organs for pollen feedi

180 n (N = 40) with a normal Nugent score at all visits had a stable lactobacilli dominated microbiota wi

181 At initial clinic visit, her blood pressure was 138/84 with an unremarkabl

182 escribed moth species known only from O'ahu, visited hermaphroditic Schiedea kaalae and S. hookeri an

183 primary outcome was a composite of repeat ED visit, hospital admission, or death within 7 days of dis

184 in-person visits, for a total of 5 in-person visits, hospitalization surveillance, telephone calls, a

185 tpatient, medication costs) and utilization (visits, hospitalizations) were compared between patients

186 omplications (including emergency department visits, hospitalizations, and urologic procedures to man

187 lar microscopy was performed during a clinic visit in cooperative children in the standard upright po

188 ween 1999 and 2013 (t0), with another clinic visit in the previous 60 days (t-1).

189 treatment (enrollment) and 6-month follow-up visits in 77 women previously classified as having spont

190 expanding IPTp-SP to all women with >/=3 ANC visits in Africa could prevent an additional 215,000 (12

191 .05% (2.23-7.75) of daily emergency hospital visits in China could be attributed to ambient PM1 and P

192 biomarker, were measured in urine from three visits in pregnancy.

193 tudy, was conducted during regular CF clinic visits in the first 12 months of life at 28 US Cystic Fi

194 insurance status and location and type of ED visits in the first year of ACA Medicaid expansion were

195 Semiannual visits included questionnaires, chart reviews, cervical/

196 4.4 to 5.4), not having to forgo a physician visit increased by 2.4 percentage points (CI, 1.9 to 2.9

197 The median duration of visits increased from 133 minutes (interquartile range,

198 ape target can be formed in a single shelter visit lasting less than 20 s, and changes in the spatial

199 study visits up to and including the week 24 visit, least squares mean difference was -1.09 units (95

200 ocal winter conditions migrating further and visiting less-productive waters; this in turn led to dif

201 s in terms of reducing unscheduled physician visits, lowering patients' anxiety and increasing self-e

202 To estimate the proportion of US ED visits made by adults with a cancer diagnosis, understan

203 t (ascertained by patient report), and study visits made outside the predefined visit windows.

204 Across all visits, mean age was 69.2 years, 51.8% were female, and

205 red to concurrent (within +/- one semiannual visit) neuropsychological testing performance.

206 y independent, random times each location is visited (Nvis) and the number of locations (Nloc) used i

207 Approximately 850000 diplopia visits occur in the United States annually; 95% were out

208 </=25 at baseline and 135 whose first study visit occurred more than 12 years from disease onset wer

209 ing the symptom in the EMR compared with new visits (odds ratio, 5.25; 95% CI, 1.69-16.30; Holm-adjus

210 ce to cataract surgery, the time to the last visit of the follow-up, date of death, or the end of the

211 e median refractive error at the age 5 years visit of the treated eyes was -2.25 D (IQR -5.13, +0.88

212 1) regimen, with mean number of postbaseline visits of 8.9 and 11.2, respectively.

213 health outcomes; and for the impact of home visiting on improving function and other health service

214 mary outcomes were emergency department (ED) visit or hospitalization for skin and soft-tissue infect

215 3-24 as the reference period, the risk of ED visit or hospitalization in the 0- to 12-month postsurge

216 ficant changes in the likelihood of a doctor visit or overnight hospital stay or health status as rep

217 0-letter visual acuity loss at 2 consecutive visits or at least a 15-letter visual acuity loss from t

218 as experienced multiple emergency department visits or hospitalizations, particularly those requiring

219 ts were more likely to have more than one ER visit (OR, 2.20; 95% CI, 1.53 to 3.16; P < .001) and rec

220 affected hs-cTnT, or MI associated with the visit, or insufficient information to determine whether

221 exhaustion, low activity, slowness) at >/=2 visits, or at 1 visit with >/=1 criteria at >/=2 visits.

222 rent emergency department visits, outpatient visits, or visits to general practitioners were observed

223 readmissions, recurrent emergency department visits, outpatient visits, or visits to general practiti

224 longitudinal cohorts with 5165 longitudinal visits over 12.8 years (median 2.8, IQR 1.6-4.6).

225 We describe longitudinal changes at 5 visits over 8 weeks in vaginal microbiota and immune med

226 contralateral RE-PMMA eyes at all follow-up visits (P < 0.05).

227 After the baseline visit, participants had 4 additional in-person visits, f

228 rns; identification of primary reason for ED visit; patient-related factors associated with inpatient

229 At both visits, patients received a complete ophthalmologic eval

230 .5%; p < 0.001) increase in total specialist visits per quarter and a 1.6% increase in GP-referred sp

231 % (507,000 over the 2,658,000 expected) more visits per quarter by the end of 2015, respectively.

232 struct a rigorous Monte Carlo algorithm that visits points in state space with a probability proporti

233 Clinical status at last pediatric clinic visit prior to transfer was described.

234 nt behaviour, as evidenced by consistency of visit rates, clientele composition, and use of cleaning

235 ot 3 or more injectable vaccines in a single visit reported being only comfortable with 1 or 2 inject

236 5.6% of 1624 children who attended follow-up visits required at least one hospitalization by 2 years

237 on and hospitalization and/or emergency room visit, respectively.

238 but approximately 16% of diplopia-related ED visits resulted in a stroke or transient ischemic attack

239 Adult cancer-related ED visits resulted in inpatient admissions more frequently

240 from cardiovascular disease until the second visit, risk factors, and CTs at baseline (b) and after a

241 Among children who participated in a home visit, serum PBDE was positively correlated with handwip

242 tegies addressing potentially preventable ED visits should be promoted to help improve patient care a

243 In post hoc analysis, clinic visits significantly increased by 43% over the first 3 w

244 y doses with sham injections on nontreatment visits starting at week 24 was initiated on meeting pres

245 normal and 10 dry eye) were enrolled in a 3-visit study consisting of 1 screening and 2 separate ran

246 return for at least one open-label follow-up visit than those who did not report injecting heroin (OR

247 uded N. gonorrhoeae isolates of patients who visited the Amsterdam STI Clinic between 1999 and 2013 (

248 icrobiomes of some IBD subjects periodically visited the HP then deviated away from it.

249 ally stable patients with ACHD who routinely visited the outpatient clinic between April 2011 and Apr

250 At the last visit, the mean intraocular pressure for the temporal gr

251 Among eyes without DDAF at first visit, the median time to develop a DDAF lesion was 4.9

252 subset of 516 MSM who had at least 3 clinic visits, there was general stability across risk classes;

253 ars) had areas of DDAF present on at least 2 visits; these eyes were included in the estimation of th

254 amount of pollen deposited during individual visits, though rarely correlated at lower taxonomic reso

255 through clinic visits and twice-weekly house visits through 52 weeks.

256 On the initial visit to our hospital, serum total IgE level was 545IU/m

257 ) letter score (VALS) from the randomization visit to the 6-month follow-up visit, based on the best-

258 rescue bronchodilator, and (3) had the first visit to the respiratory outpatient clinic within the fi

259 experienced observers require more sampling visits to detect the species.

260 is the leading cause for drug-abuse-related visits to emergency departments, most of which are due t

261 es and use by prescription medication fills, visits to eye care clinics, and cataract surgery frequen

262 in a marked increase in pollinator species, visits to flowers and interaction diversity.

263 ncy department visits, outpatient visits, or visits to general practitioners were observed.

264 tricting pharmaceutical representative sales visits to physicians (known as detailing) between 2006 a

265 ) from January 2011 (first participant first visit) to February 2013 (last participant last visit).

266 At the 6-month follow-up visit, TRS score was measured, and mood and psychologica

267 rior capsule edge was noted in postoperative visits under slit-lamp examination.

268 change in ppFEV1 from all on-treatment study visits until week 24 was 2.4 (95% CI 0.4-4.4, p=0.0182).

269 hange in LCI2.5 from baseline over all study visits up to and including the week 24 visit, least squa

270 ing costs for avoidable emergency department visits using the Billings algorithm plus inpatient and a

271 timates of annual adult emergency department visits using updated sepsis classifications.

272 The mean age of patients at the first visit was 57.9+/-13.4 years.

273 TIMPSI at first study visit was associated with risk of combined endpoint of d

274 (VISUAL-2) to the final or early termination visit was determined in each group and statistically com

275 The final follow-up visit was on August 15, 2017.

276 on of children missing two or more scheduled visits was similar in the intervention group and control

277 Children were visited weekly from enrollment to age 9 months; the moth

278 f strabismus and nystagmus at last follow-up visit were calculated.

279 anibizumab retreatments at and between study visits were also analyzed.

280 and then quarterly for 12 months and at sick visits were assessed; multiplicity of infection was eval

281 to no surveillance, one or two surveillance visits were associated with a significant reduction in c

282 12 and then protocol-driven follow-up study visits were conducted at months 18 and 36.

283 Baseline study visits were conducted in 2003 to 2007 for REGARDS, 2000

284 Household visits were made weekly for morbidity surveillance.

285 iovascular disease at baseline and follow-up visits were matched on age (+/-5 years) and sex.

286 Relatively few sampling visits were needed to estimate occupancy and detectabili

287 h rates of pediatric hospitalizations and ED visits were observed.

288 Emergency department visits were only significantly higher in methicillin-res

289 All consecutive POAG new patient visits were reviewed from each study site to determine p

290 All visits were scheduled at approximately 5-year intervals.

291 n admission to a medical ICU totaling 10,216 visits were screened for delirium by means of the Confus

292 of TTT, and tumor-foveola distance (at last visit) were found to be significant risk factors for wor

293 5086 participants (47 886 visits) were included in the analytic sample (2278 HIV-s

294 anum peruvianum, herbivory limits pollinator visits, which reduces individual plant fitness due to he

295 increase of 22.8% [from 0.12% to 0.14% of ED visits]) while the proportion of ED HZ visits decreased

296 and study visits made outside the predefined visit windows.

297 activity, slowness) at >/=2 visits, or at 1 visit with >/=1 criteria at >/=2 visits.

298 d as hospitalization or emergency department visit with a primary diagnosis of intracranial hemorrhag

299 itive associations of respiratory disease ED visits with biomass burning PM2.5; associations with die

300 dren in 2010 was defined as >/=2 IBD-related visits with one visit and >/=1 dispensed IBD-related dru

301 (60.0%) completed an ophthalmology referral visit within the study period.

302 From those patients who had repeated visits within 6 months (n=5420) and 1 year (n=6840), res